Other posts you might like:

News

Life Sciences Ontario Celebrates Excellence and Innovation in Life Sciences with 2026 Awards Announcement

TORONTO, ON – January 15th, 2026 - Life Sciences Ontario (LSO) proudly announces the recipients of the 2026 LSO Awards, ...
News, Opinion

Life Sciences Ontario (LSO) welcomes Budget 2025: Building Canada Strong and the federal government’s continued investment in innovation, research, and the life sciences sector

Ontario’s life sciences sector contributes $58.1 billion to Ontario’s GDP, generates $8.8 billion in government revenue,...
Press Release

Catalyzing Ontario’s Life Sciences Economy: Read Life Sciences Ontario’s New Report

TORONTO, ON – [25 June 2025]: Life Sciences Ontario (LSO), in partnership with Shift Health, has just released a new rep...
Announcement

LSO President and CEO Jason Field Receives King Charles III Coronation Medal

Recognition highlights leadership in advancing Ontario's life sciences sector Life Sciences Ontario (LSO) is proud to...
July 18, 2022
Uncategorized

LSO’S RESPONSE TO PMPRB INTERIM GUIDELINES CONSULATION

All stakeholders have a role in ensuring Canada can attract research and new medicine launches as we rebuild from the pandemic. In this context, LSO has provided a number of general recommendations and considerations to help guide the PMPRB’s approach for its interim guidelines period and beyond. Read LSO’s submission to learn more LSO_PMPRB interm guidelines submission_Final

Author: penny@lifesciencesontario.ca